Biohaven Ltd. (BHVN) Financials

BHVN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 466.4 million 336.9 million
Dec. 31, 2025 451.4 million 399.4 million
Sept. 30, 2025 409.1 million 426.3 million
June 30, 2025 550.4 million 415.8 million

BHVN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -149.9 million 28.3 million
Dec. 31, 2025 -130.7 million 17.0 million
Sept. 30, 2025 -145.7 million 21.5 million
June 30, 2025 -168.2 million 20.8 million

BHVN Net Income

No data available :(

BHVN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 347.8 million 280.3 million 44.3 million
Dec. 31, 2025 319.1 million 278.9 million 45.7 million
Sept. 30, 2025 260.2 million 268.3 million 45.9 million
June 30, 2025 405.0 million 257.1 million 34.5 million

BHVN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 147.6 million
Dec. 31, 2025 120.2 million
Sept. 30, 2025 105.8 million
June 30, 2025 102.4 million

BHVN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 103.8 million 26.6 million -
Dec. 31, 2025 8000 121.9 million 20.8 million -
Sept. 30, 2025 13000 141.2 million 28.2 million -
June 30, 2025 233000 184.4 million 27.3 million -

BHVN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - 960000
Sept. 30, 2025 - 1.1 million
June 30, 2025 - -

BHVN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BHVN

Price: $12.14

52 week price:
7.48
18.57

Earnings Per Share: -5.57 USD

Exchange: NYQ

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 704100

Ebitda: -42.6 million

Market Capitalization: 1.1 billion

Links: